(RESOLUTION 16-28) RESOLVED, that the ISMA support appropriate laws and/or policy to be propagated to assure that physicians are routinely notified of narcotic overdose or death of patients for whom they have prescribed narcotics in the preceding six months. (RESOLUTION 12-25A) RESOLVED, that the ISMA take action it deems appropriate to seek and support legislation banning clinics for the maintenance of opioid addiction with methadone in Indiana; and be it further RESOLVED, that the ISMA support the continued availability of methadone in Indiana for the treatment of chronic pain but not necessarily as a drug of first choice. (RESOLUTION 11-06) RESOLVED, that the ISMA encourage legislation to require methadone clinics operating in Indiana to enter prescribing data into INSPECT. (RESOLUTION 11-05) RESOLVED, that the ISMA seek legislation to regulate methadone clinics in Indiana, to identify those clients who are pregnant and supply them with accurate information about the effects of methadone on fetus development, and to educate pregnant clients on neonatal abstinence syndrome. (RESOLUTION 08-06A) RESOLVED, that the ISMA support legislation that requires methadone clinics to check their databases against INSPECT to ensure no simultaneous treatment of their patients by other physicians; and be it further, RESOLVED, that the ISMA work with our AMA delegation to change the federal statute to allow states the flexibility to require methadone clinics to report to programs like INSPECT. (RESOLUTION 07-15A) RESOLVED, that the ISMA supports inclusion of methadone clinic patients in the INSPECT program; and be it further, RESOLVED, that the ISMA support development of a statewide physician narcotic educational program with prescribing and patient monitoring guidelines.